Salvianolic acid A provides neuroprotective effects on cerebral ischemia-reperfusion injury in rats via PKA/CREB/c-Fos signaling pathway.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Urban & Fischer Verlag Country of Publication: Germany NLM ID: 9438794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-095X (Electronic) Linking ISSN: 09447113 NLM ISO Abbreviation: Phytomedicine Subsets: MEDLINE
    • Publication Information:
      Publication: Stuttgart : Urban & Fischer Verlag
      Original Publication: Stuttgart ; New York : G. Fischer, c1994-
    • Subject Terms:
      Neuroprotective Agents*/pharmacology ; Neuroprotective Agents*/therapeutic use ; Brain Ischemia*/pathology ; Reperfusion Injury*/metabolism ; Brain Injuries*/drug therapy ; Caffeic Acids* ; Lactates*; Rats ; Animals ; Rats, Sprague-Dawley ; Signal Transduction ; Apoptosis ; Infarction, Middle Cerebral Artery/drug therapy ; Infarction, Middle Cerebral Artery/pathology
    • Abstract:
      Background: Cerebral ischemia-reperfusion injury (CIRI) is a phenomenon that pathological injury of ischemic brain tissue is further aggravated after the restoration of blood supply. The complex pathological mechanism of CIRI has led to the failure of multiple neuroprotective agents in clinical studies. Salvianolic acid A (SAA) is a neuroprotective extract from Salvia miltiorrhiza Bge., with significant pharmacological activities in the treatment of brain injury. However, the neuroprotective mechanisms of SAA remain unclear.
      Purpose: To explore the potential protective effect of SAA on CIRI and its mechanism, and to provide experimental basis for the research of new drugs for CIRI.
      Study Design: A model of transient middle cerebral artery occlusion (tMCAO) in rats was used to simulate clinical CIRI, and the neuroprotective effect of SAA on tMCAO rats was investigated within 14 days after reperfusion. The improvement effects of SAA on cognitive impairment of tMCAO rats were investigated by behavioral tests from days 7-14. Finally, the neuroprotective mechanism of SAA was investigated on day 14.
      Methods: The neuroprotective effects and mechanism of SAA were investigated by behavioral tests, HE and TUNEL staining, RNA sequence (RNA-seq) analysis and Western blot in tMCAO rats.
      Results: The brain protective effects of SAA were achieved by alleviating cerebral infarction, cerebral edema, cerebral atrophy and nerve injury in tMCAO rats. Meanwhile, SAA could effectively improve the cognitive impairment and pathological damage of hippocampal tissue, and inhibit cell apoptosis in tMCAO rats. Besides, SAA could provide neuroprotective effects by up-regulating the expression of Bcl-2, inhibiting the activation of Caspase 3, and regulating PKA/CREB/c-Fos signaling pathway.
      Conclusion: SAA can significantly improve brain injury and cognitive impairment in CIRI rats, and this neuroprotective effect may be achieved through the anti-apoptotic effect and the regulation of PKA/CREB/c-Fos signaling pathway.
      Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
      (Copyright © 2023. Published by Elsevier GmbH.)
    • Contributed Indexing:
      Keywords: Apoptosis; Cerebral ischemia-reperfusion injury; PKA/CREB/c-Fos signaling pathway; Salvianolic acid A
    • Accession Number:
      0 (Neuroprotective Agents)
      51622542XO (salvianolic acid A)
      0 (Caffeic Acids)
      0 (Lactates)
    • Publication Date:
      Date Created: 20240107 Date Completed: 20240129 Latest Revision: 20240129
    • Publication Date:
      20240129
    • Accession Number:
      10.1016/j.phymed.2023.155326
    • Accession Number:
      38185068